| Z03836 | |
|
|
|
|
|
|
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 34.1 kDa | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 55-75 kDa based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4. | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
| Target Background | CEACAM6 (carcinoembryonic antigen-related cell adhesion molecule 6), is encoded by the human CEACAM6 gene. It plays a probable role in both cell-cell signaling and cell adhesion, promoting tumor progression, invasion and metastasis. It is upregulated in pancreatic adenocarcinoma, breast cancer and non-small cell lung cancer. |
| Synonyms | CEACAM6; CD66c; CEAL; NCA; CEA |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
